AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MEDADVISOR LTD

0.083

+0.0011.22%

Volume:327.72K

Turnover:26.85K

Market Cap:51.86M

PE:-8.85

High:0.083

Open:0.082

Low:0.081

Close:0.082

Loading ...

Overview Company News Filings

Why Magellan, Medadvisor, Origin Energy, and Pointsbet shares are tumbling today

Is There An Opportunity With MedAdvisor Limited's (ASX:MDR) 48% Undervaluation?

Simply Wall St.

BUZZ-Australia's MedAdvisor falls on lower qtrly revenue

BRIEF-Medadvisor Posts 2Q Operating Revenue Of A$30.8 Mln

Medadvisor - Expects Stronger Second Half Through Diversified US Pipeline for Various Health Program, Others

THOMSON REUTERS

MedAdvisor (ASX:MDR investor five-year losses grow to 66% as the stock sheds AU$14m this past week

Simply Wall St.

BRIEF-Medadvisor Provides Trading Update

BUZZ-Australia's MedAdvisor drops to 7-week low on downbeat HY outlook

Medadvisor Ltd - First Half FY25 Revenue Expected to Be Down 25-30%

THOMSON REUTERS

Medadvisor Ltd-Trading Update and Investor Briefing

THOMSON REUTERS

MedAdvisor Limited (ASX:MDR) Held Back By Insufficient Growth Even After Shares Climb 26%

Simply Wall St.

MedAdvisor Limited's (ASX:MDR) top owners are retail investors with 40% stake, while 38% is held by private companies

Simply Wall St.

MedAdvisor Limited's (ASX:MDR) market cap surged AU$17m last week, individual investors who have a lot riding on the company were rewarded

Simply Wall St.

BUZZ-Australia's MedAdvisor eyes best day in 10-mnths on strategic options evaluation

BRIEF-Medadvisor Initiated A Formal Review Process To Evaluate Strategic Options

Medadvisor Ltd - Initiated a Formal Review Process to Evaluate Strategic Options to Maximize Shareholder Value

THOMSON REUTERS

Medadvisor Ltd - No Assurance Review Process Will Result in Any Transaction or Other Change or Outcome

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MDR.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDR.AU\",,,,,undefined,":{"symbol":"MDR.AU","market":"AU","secType":"STK","nameCN":"MEDADVISOR LTD","latestPrice":0.083,"timestamp":1749190320000,"preClose":0.082,"halted":0,"volume":327716,"delay":0,"nameEN":"MEDADVISOR LTD","floatShares":393407219,"shares":624785057,"eps":-0.009378,"marketStatus":"Closed King Birthday Day","change":0.001,"latestTime":"06-06 16:12:00 AEST","open":0.082,"high":0.083,"low":0.081,"amount":26849,"amplitude":0.02439,"askPrice":0.084,"askSize":100000,"bidPrice":0.081,"bidSize":11114,"shortable":3,"etf":0,"ttmEps":-0.009378,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.082,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":1.1261168695888744,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDR.AU\",,,,,undefined,":{"symbol":"MDR.AU","floatShares":393407219,"roa":"-1.35%","roe":"-8.34%","lyrEps":0.001445,"volumeRatio":1.1261168695888744,"shares":624785057,"dividePrice":0,"high":0.083,"amplitude":0.02439,"preClose":0.082,"low":0.081,"week52Low":0.081,"pbRate":"0.92","psRate":"0.50","week52High":0.59,"institutionHeld":0,"latestPrice":0.083,"committee":-0.799953,"eps":-0.009378,"divideRate":0,"volume":327716,"delay":0,"ttmEps":-0.009378,"open":0.082,"prevYearClose":0.225,"prevWeekClose":0.083,"prevMonthClose":0.091,"prevQuarterClose":0.11,"fiveDayClose":0.091,"twentyDayClose":0.096,"sixtyDayClose":0.115},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDR.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507160006","title":"Why Magellan, Medadvisor, Origin Energy, and Pointsbet shares are tumbling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2507160006","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507160006?lang=en_us&edition=fundamental","pubTime":"2025-01-31 08:45","pubTimestamp":1738284336,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is on course to end the week on a high. At the time of writing, the benchmark index is up 0.75% to 8,556.6 points. Four ASX shares that have failed to follow the market","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/31/why-magellan-medadvisor-origin-energy-and-pointsbet-shares-are-tumbling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7062","BK7078","MDR.AU","XJO.AU","ORG.AU","BK7130","MFG.AU","PBH.AU","BK7006","BK7094","BK7507"],"gpt_icon":0},{"id":"2507704726","title":"Is There An Opportunity With MedAdvisor Limited's (ASX:MDR) 48% Undervaluation?","url":"https://stock-news.laohu8.com/highlight/detail?id=2507704726","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507704726?lang=en_us&edition=fundamental","pubTime":"2025-01-31 04:18","pubTimestamp":1738268283,"startTime":"0","endTime":"0","summary":"Using the 2 Stage Free Cash Flow to Equity, MedAdvisor fair value estimate is AU$0.36. MedAdvisor is estimated to be 48% undervalued based on current share price of AU$0.18. Analyst price target for MDR is AU$0.26 which is 28% below our fair value estimate. In this article we are going to estimate the intrinsic value of MedAdvisor Limited  by projecting its future cash flows and then discounting them to today's value. The Discounted Cash Flow  model is the tool we will apply to do this. It may sound complicated, but actually it is quite simple!We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/opportunity-medadvisor-limiteds-asx-mdr-201803633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4100","BK7094","DCF","BK4211","FCF","MDR.AU","TV"],"gpt_icon":0},{"id":"2507695655","title":"BUZZ-Australia's MedAdvisor falls on lower qtrly revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2507695655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507695655?lang=en_us&edition=fundamental","pubTime":"2025-01-30 09:30","pubTimestamp":1738200619,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's MedAdvisor falls on lower qtrly revenue** Shares of MedAdvisor MDR.AX down 5% at A$0.19** Stock hit lowest level since Dec. 27** Medical software co says Q2 FY25 operating revenue fell by 38.6% to A$30.8 million ** However, co expects stronger second half through diversified U.S. pipeline for various health program, others** Stock down 11.1% this year, as of last close  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nL3N3OQ02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDR.AU"],"gpt_icon":0},{"id":"2507693227","title":"BRIEF-Medadvisor Posts 2Q Operating Revenue Of A$30.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2507693227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507693227?lang=en_us&edition=fundamental","pubTime":"2025-01-30 09:15","pubTimestamp":1738199719,"startTime":"0","endTime":"0","summary":"BRIEF-Medadvisor Posts 2Q Operating Revenue Of A$30.8 MlnJan 30  - Medadvisor Ltd MDR.AX:2Q FY25 OPERATING REVENUE DOWN 38.6% TO A$30.8 MILLIONEXPECTS STRONGER SECOND HALF THROUGH DIVERSIFIED US PIPELINE FOR VARIOUS HEALTH PROGRAM, OTHERSFurther company coverage: MDR.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OP1T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDR.AU"],"gpt_icon":0},{"id":"2507148665","title":"Medadvisor  - Expects Stronger Second Half Through Diversified US Pipeline for Various Health Program, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2507148665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507148665?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:23","pubTimestamp":1738185818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nFWN3OP1T6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2505905892","title":"MedAdvisor (ASX:MDR investor five-year losses grow to 66% as the stock sheds AU$14m this past week","url":"https://stock-news.laohu8.com/highlight/detail?id=2505905892","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505905892?lang=en_us&edition=fundamental","pubTime":"2025-01-23 05:35","pubTimestamp":1737581708,"startTime":"0","endTime":"0","summary":"We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly. To...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-mdr/medadvisor-shares/news/medadvisor-asxmdr-investor-five-year-losses-grow-to-66-as-th","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["Y3D.SI","MDR.AU","A27.SI","BK7094"],"gpt_icon":0},{"id":"2492377004","title":"BRIEF-Medadvisor Provides Trading Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2492377004","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492377004?lang=en_us&edition=fundamental","pubTime":"2024-12-20 09:26","pubTimestamp":1734657997,"startTime":"0","endTime":"0","summary":"BRIEF-Medadvisor Provides Trading Update Dec 20  - Medadvisor Ltd MDR.AX:TRADING UPDATE AND INVESTOR BRIEFINGSEES SHIFT OF REVENUE FROM FIRST HALF TO SECOND HALF IN ITS US BUSINESSFIRST HALF FY25 REVENUE EXPECTED TO BE DOWN 25-30%EBITDA IS EXPECTED TO REMAIN POSITIVE FOR FIRST HALF AND FULL YEAR FY25.Further company coverage: MDR.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUE5DSS9D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2492437724","title":"BUZZ-Australia's MedAdvisor drops to 7-week low on downbeat HY outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2492437724","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492437724?lang=en_us&edition=fundamental","pubTime":"2024-12-20 09:25","pubTimestamp":1734657932,"startTime":"0","endTime":"0","summary":"** MedAdvisor    drops as much as 24.1% to A$0.205, lowest since Oct. 31   ** Medical software co sees group's H1 FY25 rev 25%-30% below the record $75.5 mln in 1H FY24 on lower-than-expected vaccination rates   ** Stock posts biggest intraday pct fall since Oct. 31   ** Around 1.1 mln shares traded vs the 30-day avg of 614,572   ** Stock rises 25.6% this year, as of last close ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","MDR.AU","XJO.AU","BK7094","XKO.AU"],"gpt_icon":0},{"id":"2492845374","title":"Medadvisor Ltd - First Half FY25 Revenue Expected to Be Down 25-30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492845374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492845374?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:24","pubTimestamp":1734643456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUE5DSS9D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2492556484","title":"Medadvisor Ltd-Trading Update and Investor Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=2492556484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492556484?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:24","pubTimestamp":1734643456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUE5DSS9D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDR.AU","BK7094"],"gpt_icon":0},{"id":"2489021902","title":"MedAdvisor Limited (ASX:MDR) Held Back By Insufficient Growth Even After Shares Climb 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489021902","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489021902?lang=en_us&edition=fundamental","pubTime":"2024-12-08 06:03","pubTimestamp":1733608980,"startTime":"0","endTime":"0","summary":"MedAdvisor Limited ( ASX:MDR ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-mdr/medadvisor-shares/news/medadvisor-limited-asxmdr-held-back-by-insufficient-growth-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","MDR.AU","Y3D.SI","A27.SI"],"gpt_icon":0},{"id":"2486426852","title":"MedAdvisor Limited's (ASX:MDR) top owners are retail investors with 40% stake, while 38% is held by private companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2486426852","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486426852?lang=en_us&edition=fundamental","pubTime":"2024-11-27 08:10","pubTimestamp":1732666246,"startTime":"0","endTime":"0","summary":"The considerable ownership by retail investors in MedAdvisor indicates that they collectively have a greater say in management and business strategy. A look at the shareholders of MedAdvisor Limited  can tell us which group is most powerful. With 40% stake, retail investors possess the maximum shares in the company. Put another way, the group faces the maximum upside potential .Meanwhile, private companies make up 38% of the company’s shareholders.Let's take a closer look to see what the different types of shareholders can tell us about MedAdvisor.ASX:MDR Earnings and Revenue Growth November 27th 2024. The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medadvisor-limiteds-asx-mdr-top-001046215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2484965604","title":"MedAdvisor Limited's (ASX:MDR) market cap surged AU$17m last week, individual investors who have a lot riding on the company were rewarded","url":"https://stock-news.laohu8.com/highlight/detail?id=2484965604","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484965604?lang=en_us&edition=fundamental","pubTime":"2024-11-19 08:25","pubTimestamp":1731975935,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over MedAdvisor by individual investors implies that the general public has more power...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-mdr/medadvisor-shares/news/medadvisor-limiteds-asxmdr-market-cap-surged-au17m-last-week","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["Y3D.SI","BK7094","MDR.AU","A27.SI"],"gpt_icon":0},{"id":"2483860624","title":"BUZZ-Australia's MedAdvisor eyes best day in 10-mnths on strategic options evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2483860624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483860624?lang=en_us&edition=fundamental","pubTime":"2024-11-14 09:29","pubTimestamp":1731547797,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's MedAdvisor eyes best day in 10-mnths on strategic options evaluation** Shares of MedAdvisor MDR.AX rise 18% to A$0.295, on track for its best session since Jan. 8, if current trends hold** Stock hit its highest level since Oct. 31** Medical software co initiates formal review process to evaluate strategic options to maximize shareholder value** Stock has risen 16.3% YTD, as of last close  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4N3ML043:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2483860587","title":"BRIEF-Medadvisor Initiated A Formal Review Process To Evaluate Strategic Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2483860587","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483860587?lang=en_us&edition=fundamental","pubTime":"2024-11-14 09:21","pubTimestamp":1731547311,"startTime":"0","endTime":"0","summary":"Nov 14 (Reuters) - Medadvisor Ltd   :   * INITIATED A FORMAL REVIEW PROCESS TO EVALUATE STRATEGIC OPTIONS TO MAXIMIZE SHAREHOLDER VALUE   * NO ASSURANCE REVIEW PROCESS WILL RESULT IN ANY TRANSACTION OR OTHER CHANGE OR OUTCOME Further company coverage:    (Reporting by Archishma Iyer)","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2483863456","title":"Medadvisor Ltd - Initiated a Formal Review Process to Evaluate Strategic Options to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2483863456","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483863456?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:32","pubTimestamp":1731533573,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK33U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","MDR.AU"],"gpt_icon":0},{"id":"2483863406","title":"Medadvisor Ltd - No Assurance Review Process Will Result in Any Transaction or Other Change or Outcome","url":"https://stock-news.laohu8.com/highlight/detail?id=2483863406","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483863406?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:32","pubTimestamp":1731533573,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK33U:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDR.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDR.AU\",params:#limit:5,,,undefined,":[{"date":"2022-10-28","symbol":"MDR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666911600000,"name":null,"time":"","dateTimestamp":1666875600000,"actualEps":null},{"market":"AU","date":"2022-02-25","symbol":"MDR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1645707600000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2020-11-12","symbol":"MDR.AU","type":"split","dateTimestamp":1605099600000,"forFactor":985714,"toFactor":1000000,"ratio":0.985714}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDR.AU\",market:\"AU\",,,undefined,":[]}}